Brief: Inovio Says MERS Vaccine Generates High Levels Of Antibodies And Induces Broad-Based T Cell Responses In Phase 1 Study
27/06/2018 13:10
June 27 (Reuters) - Inovio Pharmaceuticals Inc INO.O :
* INOVIO’S MERS VACCINE GENERATES HIGH LEVELS OF ANTIBODIES
AND
INDUCES BROAD-BASED T CELL RESPONSES IN PHASE 1 STUDY
* INOVIO PHARMACEUTICALS - RESULTS FOR INO-4700, WHICH IS
BEING
CO-DEVELOPED BY INOVIO AND GENEONE LIFE SCIENCE SHOWED THAT DRUG
WAS WELL-TOLERATED
* INOVIO PHARMACEUTICALS INC - PLANS TO BEGIN A PHASE 1/2
STUDY
FOR MERS VACCINE IN Q3
Source text for Eikon: ID:nGNX6cSYxc
Further company coverage: INO.O
((Reuters.Briefs@thomsonreuters.com;))